Subscribe to RSS
DOI: 10.1055/a-2457-5516
Die equine Piroplasmose: Fallberichte und epidemiologische Situation in Europa mit Fokus auf Deutschland
Equine piroplasmosis: Case descriptions and overview of the epidemiological situation in Europe with focus on GermanyZusammenfassung
Die equine Piroplasmose (EP) wird durch die Erreger Babesia (B.) caballi und Theileria (T.) equi ausgelöst und durch Schildzecken übertragen. Innerhalb Europas sind die Erreger vor allem in den Mittelmeerländern endemisch. Autochthone Infektionen können in Deutschland aufgrund einzelner Fallberichte über Infektionen ohne Auslandsaufenthalt und der geographischen Ausbreitung verschiedener Zeckenarten nicht mehr ausgeschlossen werden. Die beiden vorgestellten Fälle verdeutlichen das Risiko einer Infektion bei Auslandsreisen in endemische Regionen sowie beim Import von Pferden aus endemischen Regionen nach Deutschland. Die klinischen Symptome sind oft unspezifisch, vor allem treten Fieber, Ikterus, Lethargie, Inappetenz, Gewichtsverlust und Leistungsminderung auf. Hämatologisch sind Anämien typisch. Auch Thrombozytopenien sind beschrieben. Die Schweregrade der Zytopenien variieren von gering- bis hochgradig. Zur Diagnosestellung einer Infektion bzw. eines Erregerkontaktes sind direkte (Polymerase-Kettenreaktion, Mikroskopie von Blutausstrichen) und indirekte Nachweisverfahren (Antikörpernachweis) verfügbar. Imidocarb-Dipropionat gilt als Mittel der Wahl zur Therapie der EP. Bei Infektionen mit B. caballi scheint eine Erregerelimination möglich, wohingegen Infektionen mit T. equi trotz Therapie oft in einem lebenslangen Trägerstatus resultieren. Die Prävention beschränkt sich auf die Kontrolle bzw. Vermeidung von Zeckenkontakt. Neben möglichen schwerwiegenden klinischen Auswirkungen hat die EP auch weltweit signifikante wirtschaftliche Folgen auf den Pferdehandel. Nach den Richtlinien der WOAH wird sie als meldepflichtige Erkrankung eingestuft und die Empfehlung ausgesprochen, jedes Pferd bei grenzüberschreitenden Reisen nach den jeweiligen nationalen Bestimmungen serologisch auf die EP zu testen. In Deutschland ist die Erkrankung aktuell weder melde- noch anzeigepflichtig.
Abstract
Equine piroplasmosis (EP) is caused by Babesia (B.) caballi and Theileria (T.) equi and is transmitted by hard ticks. Predominantly, the Mediterranean region is known as being endemic for both pathogens in Europe. However, autochthonous infections in central European countries such as Germany can no longer be ruled out due to individual case reports in horses without any stays abroad as well as the geographical expansion of the habitats of different tick species. The case reports presented underline the risk of infection for horses travelling to endemic areas and in horses imported from such areas to non-endemic countries. Clinical signs are often unspecific and include fever, icterus, lethargy, inappetence, weight loss, and reduced performance. Mild to severe anemia is the most common hematologic abnormality, but thrombocytopenia has also been described. Direct (polymerase chain reaction, microscopical analysis of blood smears) and indirect detection methods (detection of antibodies) are available for the diagnosis of pathogen contact and/or infection. Imidocarb-dipropionate is recommended as treatment of choice against EP. Infections with B. caballi can be cleared, while infections with T. equi often result in a life-long carrier status despite treatment. Prevention is limited to controlling or avoiding tick contact. Aside from potentially severe and life-threatening clinical signs, equine piroplasmosis has a significant economic impact on the international trade of horses worldwide. EP is classified as a notifiable disease according to WOAH guidelines, which recommend serological screening for B. caballi and T. equi according to the respective national guidelines when travelling across borders. To date, EP is not classified as a notifiable nor reportable disease in Germany.
Publication History
Article published online:
04 December 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Qablan MA, Obornik M, Petrzelkova KJ. et al. Infections by Babesia caballi and Theileria equi in Jordanian equids: epidemiology and genetic diversity. Parasitology 2013; 140: 1096-1103
- 2 De Waal DT. Equine piroplasmosis: a review. Br Vet J 1992; 148: 6-14
- 3 Bartolome Del Pino LE, Meana A, Zini M. et al. Evidence of transplacental transmission of equine piroplasms Theileria equi and Babesia caballi in an Italian breed mare. Folia Parasitol (Praha) 2023; 70
- 4 Allsopp MT, Lewis BD, Penzhorn BL. Molecular evidence for transplacental transmission of Theileria equi from carrier mares to their apparently healthy foals. Vet Parasitol 2007; 148: 130-136
- 5 De Waal DT, van Heerden J. Infectious Diseases of Lifestock. Cape Town, South Africa: Oxford University Press; 2004
- 6 Sant C, d'Abadie R, Pargass I. et al. Prospective study investigating transplacental transmission of equine piroplasmosis in thoroughbred foals in Trinidad. Vet Parasitol 2016; 226: 132-137
- 7 Tirosh-Levy S, Gottlieb Y, Fry LM. et al. Twenty years of Equine Piroplasmosis research: global distribution, molecular diagnosis, and phylogeny. Pathogens 2020; 9
- 8 Wise LN, Pelzel-McCluskey AM, Mealey RH. et al. Equine piroplasmosis. Vet Clin North Am Equine Pract 2014; 30: 677-693
- 9 Sumbria D, Moudgil AD, Singla LD. Equine piroplasmosis: Current status. Veterinaria 2014; 1: 9-14
- 10 Chauvin A, Moreau E, Bonnet S. et al. Babesia and its hosts: adaptation to long-lasting interactions as a way to achieve efficient transmission. Vet Res 2009; 40: 37
- 11 Salim B, Bakheit MA, Kamau J. et al. Current status of equine piroplasmosis in the Sudan. Infect Genet Evol 2013; 16: 191-199
- 12 Rothschild CM. Equine piroplasmosis. J Equine Vet Sci 2013; 33: 497-508
- 13 Brüning A. Equine piroplasmosis an update on diagnosis, treatment and prevention. Br Vet J 1996; 152: 139-151
- 14 Butler CM, Oldruitenborgh-Oosterbaan MMSloet van , Stout TA. et al. Prevalence of the causative agents of equine piroplasmosis in the South West of The Netherlands and the identification of two autochthonous clinical Theileria equi infections. Vet J 2012; 193: 381-385
- 15 Dirks E, Werner G, Schwarz B. et al Equine Piroplasmosis in German-speaking countries – an underdiagnosed disease?. Prakt Tierarzt 2021; 102: 1078-1088 (in German)
- 16 Scheidemann W, Liebisch G, Liebisch A. et al Equine piroplasmosis – a case of an acute infection with Theileria equi (syn. Babesia equi) in Germany. Pferdeheilkunde 2003; 19: 16-20 (in German)
- 17 Perveen N, Muzaffar SB, Al-Deeb MA. Ticks and tick-borne diseases of livestock in the Middle East and North Africa: a review. Insects 2021; 12
- 18 Axt CW, Springer A, Strube C. et al. Molecular and serological detection of vector-borne pathogens responsible for equine piroplasmosis in Europe between 2008 and 2021. Microorganisms 2024; 12
- 19 Onyiche TE, Suganuma K, Igarashi I. et al. A review on Equine Piroplasmosis: epidemiology, vector ecology, risk factors, host immunity, diagnosis and control. Int J Environ Res Public Health 2019; 16
- 20 Wise LN, Kappmeyer LS, Silva MG. et al. Verification of post-chemotherapeutic clearance of Theileria equi through concordance of nested PCR and immunoblot. Ticks Tick Borne Dis 2018; 9: 135-140
- 21 Weiland G. Species-specific serodiagnosis of equine piroplasma infections by means of complement fixation test (CFT), immunofluorescence (IIF), and enzyme-linked immunosorbent assay (ELISA). Vet Parasitol 1986; 20: 43-48
- 22 Friedhoff KT, Soule C. An account on equine babesioses. Rev Sci Tech 1996; 15: 1191-1201
- 23 Kouam MK, Kantzoura V, Gajadhar AA. et al. Seroprevalence of equine piroplasms and host-related factors associated with infection in Greece. Vet Parasitol 2010; 169: 273-278
- 24 Mahoney DF, Wright IG, Frerichs WM. et al. The identification of Babesia equi in Australia. Aust Vet J 1977; 53: 461-464
- 25 Osman SA. Clinical, haematological and therapeutic studies on babesiosis in Arabian horses in the Qassim region, central of Saudi Arabia. J Appl Anim Res 2017; 45: 118-121
- 26 Zobba R, Ardu M, Niccolin S. et al. Clinical and laboratory findings in equine piroplasmosis. J Equine Vet Sci 2008; 28: 301-308
- 27 Mahmoud MS, El-Ezz NT, Abdel-Shafy S. et al. Assessment of Theileria equi and Babesia caballi infections in equine populations in Egypt by molecular, serological and hematological approaches. Parasit Vectors 2016; 9: 260
- 28 Hailat NQ, Lafi SQ, al-Darraji AM. et al. Equine babesiosis associated with strenuous exercise: clinical and pathological studies in Jordan. Vet Parasitol 1997; 69: 1-8
- 29 Camino E, Pozo P, Dorrego A. et al. Importance of equine piroplasmosis antibody presence in Spanish horses prior to export. Ticks Tick Borne Dis 2020; 11: 101329
- 30 Schäfer I, Silaghi C, Fischer S. et al. Detection of Anaplasma phagocytophilum in horses from Germany by molecular and serological testing (2008-2021). Vet Parasitol 2022; 312: 109840
- 31 Tirosh-Levy S, Gottlieb Y, Steinman A. Stress conditions do not affect Theileria equi parasitemia levels in sub-clinically infected horses. Ticks Tick Borne Dis 2020; 11: 101384
- 32 Joachim A, Cavalleri JMV, Berger S. Equine anaplasmosis and equine piroplasmosis in Germany, Austria and Switzerland – previously anecdotal, now relevant?. Schweiz Arch Tierheilkd 2022; 164: 35-50 (in German)
- 33 Camacho AT, Guitian FJ, Pallas E. et al. Theileria (Babesia) equi and Babesia caballi infections in horses in Galicia, Spain. Trop Anim Health Prod 2005; 37: 293-302
- 34 Alhassan A, Govind Y, Tam NT. et al. Comparative evaluation of the sensitivity of LAMP, PCR and in vitro culture methods for the diagnosis of equine piroplasmosis. Parasitol Res 2007; 100: 1165-1168
- 35 Ueti MW, Palmer GH, Scoles GA. et al. Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi . Infect Immun 2008; 76: 3525-3529
- 36 Wise LN, Kappmeyer LS, Mealey RH. et al. Review of equine piroplasmosis. J Vet Intern Med 2013; 27: 1334-1346
- 37 Ueti MW, Mealey RH, Kappmeyer LS. et al. Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk. PLoS One 2012; 7: e44713
- 38 Frerichs WM, Holbrook AA. Treatment of equine piroplasmosis (B caballi) with imidocarb dipropionate. Vet Rec 1974; 95: 188-189
- 39 Grause JF, Ueti MW, Nelson JT. et al. Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses. Vet J 2013; 196: 541-546
- 40 Laus F, Veronesi F, Passamonti F. et al. Prevalence of tick borne pathogens in horses from Italy. J Vet Med Sci 2013; 75: 715-720
- 41 Hornok S, Edelhofer R, Foldvari G. et al. Serological evidence for Babesia canis infection of horses and an endemic focus of B. caballi in Hungary. Acta Vet Hung 2007; 55: 491-500
- 42 Idoko IS, Edeh RE, Adamu AM. et al. Molecular and serological detection of piroplasms in horses from Nigeria. Pathogens 2021; 10: 508
- 43 Pikalo J, Sattler T, Eichinger M. et al. Seroprevalence of Babesia caballi and Theileria equi in horses in Central Germany. Pferdeheilkunde 2016; 32: 254-259
- 44 Sigg L, Gerber V, Gottstein B. et al. Seroprevalence of Babesia caballi and Theileria equi in the Swiss horse population. Parasitol Int 2010; 59: 313-317
- 45 Bartolome Del Pino LE, Nardini R, Veneziano V. et al. Babesia caballi and Theileria equi infections in horses in Central-Southern Italy: Sero-molecular survey and associated risk factors. Ticks Tick Borne Dis 2016; 7: 462-469
- 46 Montes Cortes MG, Fernandez-Garcia JL, Habela Martinez-Estellez MA. Seroprevalence of Theileria equi and Babesia caballi in horses in Spain. Parasite 2017; 24: 14
- 47 Nadal C, Marsot M, Le Metayer G. et al. Spatial and temporal circulation of Babesia caballi and Theileria equi in France based on seven years of serological data. Pathogens 2022; 11: 227
- 48 Fritz CL. Emerging tick-borne diseases. Vet Clin North Am Small Anim Pract 2009; 39: 265-278
- 49 Moretti A, Mangili V, Salvatori R. et al. Prevalence and diagnosis of Babesia and Theileria infections in horses in Italy: a preliminary study. Vet J 2010; 184: 346-350
- 50 Probst J, Springer A, Strube C. Year-round tick exposure of dogs and cats in Germany and Austria: results from a tick collection study. Parasit Vectors 2023; 16: 70
- 51 Probst J, Springer A, Topp AK. et al. Winter activity of questing ticks (Ixodes ricinus and Dermacentor reticulatus) in Germany – Evidence from quasi-natural tick plots, field studies and a tick submission study. Ticks Tick Borne Dis 2023; 14: 102225
- 52 Liebisch A, Rahman MS. [Prevalence of the ticks Dermacentor marginatus (Sulzer, 1776) and Dermacentor reticulatus (Fabricius, 1794) and their importance as vectors of diseases in Germany (author's transl)]. Tropenmed Parasitol 1976; 27: 393-404
- 53 Springer A, Lindau A, Probst J. et al. Update and prognosis of Dermacentor distribution in Germany: Nationwide occurrence of Dermacentor reticulatus . Front Vet Sci 2022; 9: 1044597
- 54 Engik K. [Weitere Untersuchungen zur Überträgerfrage der Pferdepiroplasmose]. Archiv für wissenschaftliche und praktische Tierheilkunde 1944; 79: 58-80
- 55 Scoles GA, Ueti MW. Vector ecology of equine piroplasmosis. Annu Rev Entomol 2015; 60: 561-580
- 56 Drehmann M, Springer A, Lindau A. et al. The spatial distribution of Dermacentor ticks (Ixodidae) in Germany-Evidence of a continuing spread of Dermacentor reticulatus . Front Vet Sci 2020; 7: 578220
- 57 Jongejan F, Ringenier M, Putting M. et al. Novel foci of Dermacentor reticulatus ticks infected with Babesia canis and Babesia caballi in the Netherlands and in Belgium. Parasit Vectors 2015; 8: 232
- 58 Springer A, Ehrmann C, Lembcke M. et al. Theileria equi-infection in 2 German horses returning from a trail ride in southern France. Tierarztl Prax Ausg G Grosstiere Nutztiere 2020; 48: 124-129